NIH-funded research Sbir 2 grant

A new device to measure hepcidin in urine for detecting iron deficiency in children and teens

Official title: Novel Point-of-Care Device for Urinary Hepcidin to Detect Iron Deficiency in Children and Adolescents

Funded at Intrinsic Lifesciences, LLC · NIH-10709598 · Data updated 2026-11-12

This study is testing a new, easy-to-use device that helps doctors quickly check for iron deficiency in kids and teens by measuring a substance in their urine, so they can get the help they need to grow and develop properly.

More Iron Deficiency research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionIntrinsic Lifesciences, LLC
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 25, 2022
Project endAugust 31, 2025
Funding year2023
Award (this year)$788,664
NIH project number5R44DK135139-02
Project IDNIH-10709598 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include children and adolescents who may be at risk for iron deficiency, particularly those showing signs of cognitive or physical developmental issues.

Less likely to help

Patients who are not children or adolescents, or those who do not exhibit symptoms of iron deficiency, may not benefit from this research.

What this research studies

This research focuses on developing a non-invasive point-of-care device that measures urinary hepcidin levels to diagnose iron deficiency in children and adolescents. Iron deficiency is a significant health issue that can affect cognitive and physical development, even in the absence of anemia. The proposed device aims to provide pediatricians with a reliable and easy-to-use tool to assess iron status quickly. By quantifying urinary hepcidin normalized to urinary creatinine, the device could facilitate timely interventions for affected children.

Why it matters

Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of iron deficiency in children, improving their health outcomes and development.

How similar studies have gone: Previous research has shown that measuring hepcidin levels can effectively indicate iron status, suggesting that this approach has potential for success.

Where this research is happening

  • Intrinsic Lifesciences, LLC
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Ostland, Vaughn E — Intrinsic Lifesciences, LLC
  • Study coordinator: Ostland, Vaughn E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.